CCR1 inhibition ameliorates the progression of lupus nephritis in NZB/W mice

Journal of Immunology

Volumn 192, Issue 3, 2014, Pages 886-896

  Bignon, Alexandre ^a,b   Gaudin, Françoise ^a,b   Hémon, Patrice ^a,b   Tharinger, Hugo ^c   Mayol, Katia ^d   Walzer, Thierry ^d   Loetscher, Pius ^e   Peuchmaur, Michel ^f,g   Berrebi, Dominique ^b,f,g   Balabanian, Karl ^a,b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b INSERM   (France)

^c Institut Fédératif de Recherche 141   (France)

^d CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

^e NOVARTIS PHARMA AG   (Switzerland)

^f HÔPITAL ROBERT DEBRÉ   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BL 5923; CHEMOKINE RECEPTOR CCR1; CHEMOTAXIS INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CELLULAR IMMUNITY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; EFFECTOR CELL; FEMALE; GLOMERULONEPHRITIS; HUMORAL IMMUNITY; INTERSTITIAL NEPHRITIS; KIDNEY INJURY; LEUKOCYTE; LIFESPAN; LUPUS ERYTHEMATOSUS NEPHRITIS; LY6C+ MONOCYTE; MACROPHAGE; MALE; MEMORY T LYMPHOCYTE; MONOCYTE; MONONUCLEAR PHAGOCYTE; MOUSE; NEUTROPHIL; NEW ZEALAND BLACK MOUSE; NEW ZEALAND WHITE MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEINURIA; T LYMPHOCYTE;

AGE FACTORS; ANIMALS; B-LYMPHOCYTES; CHEMOKINE CCL3; CHEMOKINE CCL5; CHEMOTAXIS, LEUKOCYTE; DISEASE PROGRESSION; DRUG EVALUATION, PRECLINICAL; HUMANS; KIDNEY; LIGANDS; LUPUS NEPHRITIS; MICE; MICE, INBRED NZB; MYELOID CELLS; NEUTROPHIL INFILTRATION; RANDOM ALLOCATION; RECEPTORS, CCR1; RNA, MESSENGER; SPLEEN; SPLENOMEGALY; T-LYMPHOCYTE SUBSETS;

EID: 84893374540     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300123     Document Type: Article

References (47)

1. Rahman, A., and D. A. Isenberg. 2008. Systemic lupus erythematosus. N. Engl. J. Med. 358: 929-939.
2. Tsokos, G. C. 2011. Systemic lupus erythematosus. N. Engl. J. Med. 365: 2110-2121.
3. Lech, M., and H. J. Anders. 2013. The pathogenesis of lupus nephritis. J. Am. Soc. Nephrol. 24: 1357-1366.
4. Saxena, R., T. Mahajan, and C. Mohan. 2011. Lupus nephritis: current update. Arthritis Res. Ther. 13: 240.
5. Davidson, A., and C. Aranow. 2010. Lupus nephritis: lessons from murine models. Nat. Rev. Rheumatol. 6: 13-20.
6. Holdsworth, S. R., and P. G. Tipping. 2007. Leukocytes in glomerular injury. Semin. Immunopathol. 29: 355-374.
7. Borchers, A. T., N. Leibushor, S. M. Naguwa, G. S. Cheema, Y. Shoenfeld, and M. E. Gershwin. 2012. Lupus nephritis: a critical review. Autoimmun. Rev. 12: 174-194.
8. Teramoto, K., N. Negoro, K. Kitamoto, T. Iwai, H. Iwao, M. Okamura, and K. Miura. 2008. Microarray analysis of glomerular gene expression in murine lupus nephritis. J. Pharmacol. Sci. 106: 56-67.
9. Anders, H. J., V. Vielhauer, M. Frink, Y. Linde, C. D. Cohen, S. M. Blattner, M. Kretzler, F. Strutz, M. Mack, H. J. Grone, et al. 2002. A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. J. Clin. Invest. 109: 251-259.
10. Anders, H. J., and M. Ryu. 2011. Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. Kidney Int. 80: 915-925.
11. Thelen, M., and J. V. Stein. 2008. How chemokines invite leukocytes to dance. Nat. Immunol. 9: 953-959.
12. Ohl, K., and K. Tenbrock. 2011. Inflammatory cytokines in systemic lupus erythematosus. J. Biomed. Biotechnol. 2011: 432595.
13. Lionakis, M. S., B. G. Fischer, J. K. Lim, M. Swamydas, W. Wan, C. C. Richard Lee, J. I. Cohen, P. Scheinberg, J. L. Gao, and P. M. Murphy. 2012. Chemokine receptor Ccr1 drives neutrophil-mediated kidney immunopathology and mortality in invasive candidiasis. PLoS Pathog. 8: e1002865.
14. Furuichi, K., J. L. Gao, R. Horuk, T. Wada, S. Kaneko, and P. M. Murphy. 2008. Chemokine receptor CCR1 regulates inflammatory cell infiltration after renal ischemia-reperfusion injury. J. Immunol. 181: 8670-8676.
15. Turner, J. E., H. J. Paust, S. B. Bennstein, P. Bramke, C. Krebs, O. M. Steinmetz, J. Velden, F. Haag, R. A. Stahl, and U. Panzer. 2012. Protective role for CCR5 in murine lupus nephritis. Am. J. Physiol. Renal Physiol. 302: F1503-F1515.
16. Pérez de Lema, G., H. Maier, E. Nieto, V. Vielhauer, B. Luckow, F. Mampaso, and D. Schlondorff. 2001. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J. Am. Soc. Nephrol. 12: 1369-1382.
17. Anders, H. J., E. Belemezova, V. Eis, S. Segerer, V. Vielhauer, G. Perez de Lema, M. Kretzler, C. D. Cohen, M. Frink, R. Horuk, et al. 2004. Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice. J. Am. Soc. Nephrol. 15: 1504-1513.
18. Ninichuk, V., A. G. Khandoga, S. Segerer, P. Loetscher, A. Schlapbach, L. Revesz, R. Feifel, A. Khandoga, F. Krombach, P. J. Nelson, et al. 2007. The role of interstitial macrophages in nephropathy of type 2 diabetic db/db mice. Am. J. Pathol. 170: 1267-1276.
19. Adalid-Peralta, L., A. Mathian, T. Tran, L. Delbos, I. Durand-Gasselin, D. Berrebi, M. Peuchmaur, J. Couderc, D. Emilie, and S. Koutouzov. 2008. Leukocytes and the kidney contribute to interstitial inflammation in lupus nephritis. Kidney Int. 73: 172-180.
20. Perry, D., A. Sang, Y. Yin, Y. Y. Zheng, and L. Morel. 2011. Murine models of systemic lupus erythematosus. J. Biomed. Biotechnol. 2011: 271694.
21. Cockwell, P., A. J. Howie, D. Adu, and C. O. Savage. 1998. In situ analysis of C-C chemokine mRNA in human glomerulonephritis. Kidney Int. 54: 827-836.
22. Furuichi, K., T. Wada, N. Sakai, Y. Iwata, K. Yoshimoto, M. Shimizu, K. Kobayashi, K. Takasawa, H. Kida, S. I. Takeda, et al. 2000. Distinct expression of CCR1 and CCR5 in glomerular and interstitial lesions of human glomerular diseases. Am. J. Nephrol. 20: 291-299.
23. Vielhauer, V., E. Berning, V. Eis, M. Kretzler, S. Segerer, F. Strutz, R. Horuk, H. J. Grone, D. Schlondorff, and H. J. Anders. 2004. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome. Kidney Int. 66: 2264-2278.
24. Owen, J. L., M. F. Criscitiello, S. Libreros, R. Garcia-Areas, K. Guthrie, M. Torroella-Kouri, and V. Iragavarapu-Charyulu. 2011. Expression of the inflammatory chemokines CCL2, CCL5 and CXCL2 and the receptors CCR1-3 and CXCR2 in T lymphocytes from mammary tumor-bearing mice. Cell. Immunol. 270: 172-182.
25. Ajuebor, M. N., C. M. Hogaboam, T. Le, A. E. Proudfoot, and M. G. Swain. 2004. CCL3/MIP-1alpha is pro-inflammatory in murine T cell-mediated hepatitis by recruiting CCR1-expressing CD4(+) T cells to the liver. Eur. J. Immunol. 34: 2907-2918.
26. Schaller, M. A., L. E. Kallal, and N. W. Lukacs. 2008. A key role for CC chemokine receptor 1 in T-cell-mediated respiratory inflammation. Am. J. Pathol. 172: 386-394.
27. Anders, H. J., V. Ninichuk, and D. Schlondorff. 2006. Progression of kidney disease: blocking leukocyte recruitment with chemokine receptor CCR1 antagonists. Kidney Int. 69: 29-32.
28. Ramos, M. V., C. Auvynet, L. Poupel, M. Rodero, M. P. Mejias, C. A. Panek, S. Vanzulli, C. Combadiere, and M. Palermo. 2012. Chemokine receptor CCR1 disruption limits renal damage in a murine model of hemolytic uremic syndrome. Am. J. Pathol. 180: 1040-1048.
29. Gao, J. L., and P. M. Murphy. 1995. Cloning and differential tissue-specific expression of three mouse beta chemokine receptor-like genes, including the gene for a functional macrophage inflammatory protein-1 alpha receptor. J. Biol. Chem. 270: 17494-17501.
30. Cook, D. N., M. A. Beck, T. M. Coffman, S. L. Kirby, J. F. Sheridan, I. B. Pragnell, and O. Smithies. 1995. Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 269: 1583-1585.
31. Revesz, L., B. Bollbuck, T. Buhl, J. Dawson, R. Feifel, R. Heng, P. Hiestand, H. Sparrer, A. Schlapbach, and R. Waelchli. 2006. Bridged piperazines and piperidines as CCR1 antagonists with oral activity in models of arthritis and multiple sclerosis. Lett. Drug Des. Discov. 3: 689-694.
32. Balabanian, K., E. Brotin, V. Biajoux, L. Bouchet-Delbos, E. Lainey, O. Fenneteau, D. Bonnet, L. Fiette, D. Emilie, and F. Bachelerie. 2012. Proper desensitization of CXCR4 is required for lymphocyte development and peripheral compartmentalization in mice. Blood 119: 5722-5730.
33. Rutledge, R. G., and C. Côté. 2003. Mathematics of quantitative kinetic PCR and the application of standard curves. Nucleic Acids Res. 31: e93.
34. Hill, G. S., M. Delahousse, D. Nochy, and J. Bariéty. 2005. Class IV-S versus class IV-G lupus nephritis: clinical and morphologic differences suggesting different pathogenesis. Kidney Int. 68: 2288-2297.
35. Balabanian, K., J. Couderc, L. Bouchet-Delbos, A. Amara, D. Berrebi, A. Foussat, F. Baleux, A. Portier, I. Durand-Gasselin, R. L. Coffman, et al. 2003. Role of the chemokine stromal cell-derived factor 1 in autoantibody production and nephritis in murine lupus. J. Immunol. 170: 3392-3400.
36. Theofilopoulos, A. N., and F. J. Dixon. 1985. Murine models of systemic lupus erythematosus. Adv. Immunol. 37: 269-390.
37. Ramos, C. D., C. Canetti, J. T. Souto, J. S. Silva, C. M. Hogaboam, S. H. Ferreira, and F. Q. Cunha. 2005. MIP-1alphaCCL3 acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-Alpha and LTB4. J. Leukoc. Biol. 78: 167-177.
38. Bonecchi, R., N. Polentarutti, W. Luini, A. Borsatti, S. Bernasconi, M. Locati, C. Power, A. Proudfoot, T. N. Wells, C. Mackay, et al. 1999. Up-regulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by IFNgamma in human neutrophils. J. Immunol. 162: 474-479.
39. Banas, B., B. Luckow, M. Moller, C. Klier, P. J. Nelson, E. Schadde, M. Brigl, D. Halevy, H. Holthofer, B. Reinhart, and D. Schlondorff. 1999. Chemokine and chemokine receptor expression in a novel human mesangial cell line. J. Am. Soc. Nephrol. 10: 2314-2322.
40. Mo, R., J. Chen, A. Grolleau-Julius, H. S. Murphy, B. C. Richardson, and R. L. Yung. 2005. Estrogen regulates CCR gene expression and function in T lymphocytes. J. Immunol. 174: 6023-6029.
41. Lengi, A. J., R. A. Phillips, E. Karpuzoglu, and S. A. Ahmed. 2007. Estrogen selectively regulates chemokines in murine splenocytes. J. Leukoc. Biol. 81: 1065-1074.
42. Eis, V., B. Luckow, V. Vielhauer, J. T. Siveke, Y. Linde, S. Segerer, G. Perez De Lema, C. D. Cohen, M. Kretzler, M. Mack, et al. 2004. Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction. J. Am. Soc. Nephrol. 15: 337-347.
43. Ninichuk, V., O. Gross, C. Reichel, A. Khandoga, R. D. Pawar, R. Ciubar, S. Segerer, E. Belemezova, E. Radomska, B. Luckow, et al. 2005. Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease. J. Am. Soc. Nephrol. 16: 977-985.
44. Ishikawa, S., T. Sato, M. Abe, S. Nagai, N. Onai, H. Yoneyama, Y. Zhang, T. Suzuki, S. Hashimoto, T. Shirai, et al. 2001. Aberrant high expression of B lymphocyte chemokine (BLC/CXCL13) by C11b+CD11c+ dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC. J. Exp. Med. 193: 1393-1402.
45. Nelson, P. J., A. J. Rees, M. D. Griffin, J. Hughes, C. Kurts, and J. Duffield. 2012. The renal mononuclear phagocytic system. J. Am. Soc. Nephrol. 23: 194-203.
46. Lin, S. L., A. P. Castano, B. T. Nowlin, M. L. Lupher, Jr., and J. S. Duffield. 2009. Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations. J. Immunol. 183: 6733-6743.
47. Turner, J. E., H. J. Paust, O. M. Steinmetz, A. Peters, C. Meyer-Schwesinger, F. Heymann, U. Helmchen, S. Fehr, R. Horuk, U. Wenzel, et al. 2008. CCR5 deficiency aggravates crescentic glomerulonephritis in mice. J. Immunol. 181: 6546-6556.